An Accessorised Prefilled Syringe to an Autoinjector Pharmacokinetic Bridging Study of Tozorakimab

NCT06908577 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

254

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Tozorakimab
DEVICE: Autoinjector (AI) Device
DEVICE: Accessorised Prefilled Syringe (APFS) Device

Sponsor

AstraZeneca

Collaborators

[object Object]